JTT-251

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameJTT-251
Drug Alias NameJTT-251
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPyruvate dehydrogenase kinase inhibitors
TargetsPyruvate dehydrogenase kinase
Therapy Area/IndicationsDiabetes MellitusPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJapan Tobacco (Hong Kong) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAkros Pharma Inc
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusPulmonary Arterial Hypertension

Other Information

ATC CodeN/A
Related LinksN/A